Precision VIR Announces Non-surgical Option for Patients with Varicose Veins

Vein expert doctors at Precision VIR in Dallas, TX announce Varithena as a non-surgical option for varicose vein patients. Sadly, vein disease does not cure itself and can get worse if untreated. Precision VIR can reduce varicose vein symptoms and improve leg appearance.

Dallas, United States - April 17, 2018 /PressCable/ —

Precision VIR Announces Availability of Varithena® as a Non-Surgical Option for Patients with Symptoms Related to or Caused by Varicose Veins

The Cutting-Edge Procedure can Reduce a Variety of Symptoms and Improve Vein Appearance

Dallas, TX (April 16, 2018) – The doctors at Precision Vascular & Interventional recently announced they incorporated Varithena® (polidocanol injectable foam) into the growing list of superior vein treatment options for their patients. Varithena is a non-surgical prescription medicine many believe can be a game-changer when it comes to treating varicose veins, specifically in combating the symptoms of heaviness, achiness, swelling, throbbing and itching.

“Precision VIR is delighted to provide patients with this non-surgical option,” Dr. Danny Chan said on behalf of himself, Dr. Jaryd Stein, and their associate vein specialists. “We have been specially trained in using Varithena. Treatment is minimally-invasive—which means no incision is required.”

Dr. Chan added, “The Varithena procedure usually takes less than one hour, and patients may resume light activities as quickly as the same day of treatment.”

More About Varicose Veins and Varithena

Varicose veins are enlarged bulging veins usually found above the surface of the skin on the legs and are a telltale sign of vein disease, where vein walls and valves have become weakened and eventually interrupt normal blood flow. These veins can range from the most common spider and varicose veins to skin breakdown and venous ulcers. More than 20 million Americans suffer from vein disease or venous disorders.

Sadly, vein disease does not cure itself and can get worse if left untreated. Luckily, there are a variety of treatment options available for patients with venous conditions, including Varithena, Sclerotherapy, ClosureFast, and Microphlebectomy.

Varithena (polidocanol injectable foam) is the latest option. It is administered through a catheter or by direct injection into the malfunctioning vein. The foam fills the desired section of the vein, and the diseased vein collapses. Blood flow then shifts to healthier veins nearby. This procedure does not require incisions. While the doctor usually numbs the injection site, no additional anesthesia is required.

Varithena treats a wide range of varicose veins in the GSV system, including:

• Tortuous (twisted) veins

• Veins above and below the knee

• Veins with small, medium, and large diameters

• Veins previously treated with other methods

Varithena® is a registered trademark of Provensis Ltd, a BTG International group company.

Precision VIR – Committed to Helping Patients Lead Normal Lives

Precision VIR has long been at the forefront of performing leading-edge procedures to treat vein disease such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and peripheral arterial disease/peripheral vascular disease (PAD/PVD)—all while providing compassionate patient care.

With multiple locations in the Dallas-Fort Worth area, Precision VIR was established in 2012 as the first independent Vascular and Interventional Radiology practice in North Texas. They focus only on minimally-invasive procedures and surgeries that are the safest and most efficient options for patients. There are no large incisions, which allows for a reduction in risk, less pain, and shorter recovery time.

All physicians at Precision VIR are Board Certified Diagnostic Radiologists with additional Fellowship training in Vascular and Interventional Radiology. Precision VIR serves Dallas, Fort Worth, Carrollton, Richardson, Garland, Mesquite, Highland Park, University Park, Park Cities, Plano, Frisco, Allen, McKinney, Flower Mound, Lewisville, Denton, Arlington, Irving, Grand Prairie and all of North Texas. Precision VIR doctors are area leaders in vascular disease diagnosis and treatment for conditions such as varicose veins, spider veins, deep vein thrombosis (DVT), chronic venous insufficiency (CVI), peripheral arterial disease/peripheral vascular disease (PAD/PVD), IVC filters, women’s pelvic congestion syndrome, male varicoceles and female uterine fibroids.

For more information on Varithena, visit the Precision VIR FAQ page or to see if this procedure is the right treatment for your varicose veins, schedule a consultation by calling (214) 382-3200.

– end –

###

Contact Info:
Name: Shauna Robinson or Madison Horan
Email: info@precisionvir.com
Organization: Precision VIR
Address: 12400 Coit Road, Suite 505, Dallas, TX 75251, United States
Phone: +1-214-382-3200

For more information, please visit https://www.precisionvir.com/vein-care-dallas/

Source: PressCable

Release ID: 331770

More News From Banking Reporter

Brazilian leader at odds with Davos focus on environment

Jan 22, 2019

DAVOS, Switzerland — Brazilian President Jair Bolsonaro pledged to work "in harmony with the world" to cut carbon emissions, aiming to quell international concerns that his country, the main custodian of the oxygen-rich Amazon, could put economic interests over environmental ones. The environment dominated talks at the World Economic Forum on Tuesday, and the nationalist leader struck a conciliatory tone in a keynote speech — a far cry from the combative one he had taken on the campaign trail when he once threatened to join the United States and pull Brazil out of the Paris climate accord, which set a...

The Latest: Merck to ship 120,000 more Ebola vaccine doses

Jan 22, 2019

DAVOS, Switzerland — The Latest on the World Economic Forum in Davos, Switzerland (all times local): 6:30 p.m. Drugmaker Merck says it will ship another approximately 120,000 doses of an experimental Ebola vaccine to Congo by the end of next month amid the second deadliest outbreak in history. Associate Vice President Lydia Ogden told the World Economic Forum that the company is committed to having a ready stockpile of 300,000 doses and already has shipped 100,000 to the World Health Organization. Health officials have called the experimental vaccine highly effective against the virus. Congo's health ministry says more than 63,000...

World shares retreat on fears of global, Chinese slowdown

Jan 22, 2019

SINGAPORE — World markets fell Tuesday after the International Monetary Fund trimmed its global outlook for 2019 and 2020 and China said its economy grew at the slowest pace in nearly 30 years. KEEPING SCORE: Germany's DAX gave up 0.5 percent to 11,076 and France's CAC 40 was down 0.7 percent at 4,834. Britain's FTSE 100 was 0.5 percent lower at 6,934. Wall Street, reopening after Martin Luther King Jr. Day, was set for early losses. Futures for the broad S&P 500 index declined 0.7 percent and Dow futures dropped 0.6 percent. THE DAY IN ASIA: Japan's Nikkei 225 index...

Investor sentiment for Germany ticks up, but still depressed

Jan 22, 2019

FRANKFURT, Germany — A survey of financial experts suggests the outlook for Germany, Europe's largest economy, brightened slightly during January because the worst risks were already reflected in earlier months' readings. The ZEW institute's indicator rose 2.5 points over December's reading to minus 15.0 points. That is still far below the long-term average of plus 22.4 points. ZEW President Achim Wambach said Tuesday earlier surveys were down sharply as respondents anticipated risks to German growth such as a disorderly departure from the European Union by Britain or weaker growth in major trade partner China. He said: "It is remarkable that...

Asian shares decline on concerns over global, China slowdown

Jan 22, 2019

SINGAPORE — Asian markets were mostly lower on Tuesday after the International Monetary Fund trimmed its global outlook for 2019 and 2020. The downgrade came after China said its economy grew at the slowest pace in 30 years in the last quarter of 2018. Wall Street was closed for a holiday on Monday. KEEPING SCORE: Japan's Nikkei 225 index shed 0.7 percent to 20,573.28 and the Kospi in South Korea sank 0.7 percent to 2,110.62. Hong Kong's Hang Seng lost 1.0 percent to 26,921.49. The Shanghai Composite index fell 0.7 percent to 2,591.37. Australia's S&P ASX 200 slipped 0.6 percent...

About Us

Banking Reporter is the largest-circulated online business news in the United States, bringing a whole new genre of business journalism more up close and more incisive.

Contact us: sales[at]bankingreporter.com

Subscribe Now!